C

Centenial Surgical Suture Limited

CSURGSU
Market snapshot · 2026-08-10 20:26 UTC

82.05

₹-2.95 (-3.47%)

MARKET CAP

₹29.93 Cr

STOCK P/E

52W HIGH

₹189.00

52W LOW

₹73.04

BOOK VALUE

₹78.24

EPS

₹-6.04

ROE

-7.43%

SECTOR

Health Care

DEBT/EQUITY

106.39

VOLUME

89

P/B RATIO

1.05x

PEG RATIO

Sector

Health Care

Themes

Health Care Equipment & Supplies
₹157.95₹136.76₹115.57₹94.39₹73.20VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

EV/EBITDA
Undervalued

5Y Average

12.98

Current

11.81

Overvalued

16.55

Undervalued

8.77

P/S
Strongly Undervalued

5Y Average

0.61

Current

0.56

Overvalued

0.70

Undervalued

0.52

P/B
Strongly Undervalued

5Y Average

1.26

Current

1.05

Overvalued

1.45

Undervalued

1.07

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹13 CrMar 2026

Latest net profit

₹-2.31 CrMar 2026

Latest EPS

₹-6.33Mar 2026

Net margin

7.4%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%4.0%8.0%12.0%16.0%-5.00 Cr0.00 Cr5.00 Cr10 Cr15 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr₹-9₹-6₹-3₹0₹3
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-5.00 Cr0.00 Cr5.00 Cr10 Cr15 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-30 Cr0.00 Cr30 Cr60 Cr90 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +13.0213.6613.1012.3812.0513.7414.2712.2013.3112.9413.4614.8612.58
Expenses +11.9212.5011.9611.1910.5412.0212.5411.4511.2511.7112.0713.3311.65
Operating Profit1.101.161.141.191.511.721.730.752.061.231.391.530.93
OPM %8.45%8.49%8.70%9.61%12.53%12.52%12.12%6.15%15.48%9.51%10.33%10.30%7.39%
Other Income +0.030.010.020.060.030.000.060.010.050.000.050.050.07
Interest0.520.480.520.510.950.530.530.502.190.320.460.352.21
Depreciation0.310.300.320.330.440.791.091.111.260.950.991.041.02
Profit before tax0.300.390.320.410.150.400.17-0.85-1.34-0.04-0.010.19-2.23
Tax %53.33%25.64%28.12%24.39%-26.67%25.00%23.53%0.00%-11.19%0.00%0.00%26.32%4.04%
Net Profit +0.140.290.240.310.190.300.13-0.85-1.18-0.04-0.010.15-2.31
EPS in Rs0.380.790.660.850.520.820.36-2.33-3.23-0.11-0.030.41-6.33
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +46.89%46.89%46.89%46.89%46.89%
Public +53.11%53.11%53.11%53.11%53.11%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026

Aug 03, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 08, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

Jun 24, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 23, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Jun 03, 2026PDFCompany Reports Open